Arsanis
A company developing targeted monoclonal antibody immunotherapies for the treatment of infectious diseases
3
Funding Rounds
$75.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Er*** An****** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Arsanis has raised a total of $30m in funding over 3 rounds.
Key Insights:
- Arsanis Series B round: $20m
- Arsanis Series A round: $10m
- Arsanis funding round, April 2017: $45.5m
Arsanis Series B round
$20m
Arsanis Series A round
$10m
Arsanis funding round, April 2017
$45.5m